Eckhard Schueler

Title: The Innovative Contributions of Eckhard Schueler

Introduction

Eckhard Schueler is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of virology, particularly in the inactivation of viruses in plasma protein solutions. His work is essential for ensuring the safety and efficacy of therapeutic plasma products.

Latest Patents

Eckhard Schueler holds a patent for a process aimed at the inactivation of viruses. This patent describes a method for eliminating both coated and noncoated viruses from a plasma protein solution. The process involves the addition of an ammonium salt at alkaline pH levels, followed by incubation at room temperature. The solution is then pasteurized at approximately 60°C for several hours after the separation of precipitates and removal of the ammonium salt, resulting in a therapeutically employable plasma protein preparation. He has 1 patent to his name.

Career Highlights

Eckhard Schueler is associated with Aventis Behring GmbH, where he has contributed to advancements in the field of biopharmaceuticals. His innovative approach to virus inactivation has implications for the safety of blood products and other therapeutic applications.

Collaborations

Throughout his career, Eckhard has worked alongside esteemed colleagues such as Gerhardt Kumpe and Thomas Nowak. Their collaborative efforts have furthered research and development in the biopharmaceutical sector.

Conclusion

Eckhard Schueler’s contributions to the field of virology and plasma protein safety are invaluable. His innovative patent and work at Aventis Behring GmbH highlight the importance of research in developing safe therapeutic solutions.